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Background: Implantation of Drug-eluting stents (DES) is associated with delayed reendothelialization and endothelial dysfunction and thus 
may contribute to in stent-restenosis and late stent thrombosis. Rosiglitazone activates ,,PPARgamma“, a transcription factor involved in the 
control of inflammation, apoptosis and cell proliferation. We hypothesized that local rosiglitazone treatment using coated stents (RDES) improves 
reendothelialization by different gene expression of vasoactive and vasoprotective genes, regulating vascular tone, growth and endothelial function in 
comparison to Bare Metal Stent (BMS).
Methods: In 5 pigs, RDES and BMS were randomly implanted in coronary arteries with an overexpansion (ballon/stent to artery ratio 1.3-1.5:1) 
in order to disrupt the endothelial layer and to induce inflammation and neointimal hyperplasia. The expression of vasoactive and vasoprotective 
genes (eNOS, C-natriuretic Peptide (CNP), adiponectin, endothelin-1) were evaluated after 3 months by quantitative real time RT-PCR. Additionally, 
endothelial expression of CD31 was analyzed by immunohistochemistry.
Results:
 
UCA: uninjured coronary arteries
Conclusions: 3 month after implantation of RDES not only reendotheliazation was complete, but also the endothelium appears functional, 
supported by a beneficial vascular gene expression profile in comparison to BMS. Intracoronary rosiglitazone treatment therefore may prevent in 
stent-restenosis and late stent thrombosis.
